Rite Aid’s pilot of CBD sales follows similar tests disclosed in just the last month by CVS Health and Walgreens Boots Alliance, which are all seeing intensifying reimbursement pressure for prescription drugs. “We've heard from many customers about their interest in purchasing CBD products,” Rite Aid chief operating officer Bryan Everett told analysts Thursday on the company’s fourth quarter earnings call. “The CBD-related items we plan to carry are non-THC containing topical creams, patches and sprays,” Walgreens spokesman Phil Caruso said. “The products includes topicals such as creams, sprays, roll-ons, lotions and salves,” CVS spokesman Michael DeAngelis said. “We are working with several CBD product manufacturers that are complying with applicable laws and that meet CVS’s high standards for quality,” CVS’ spokesman said.

Source: Forbes April 12, 2019 12:52 UTC